Skip to main content
Caplight Logo









arcoris bio

arcoris bio

Private
SchlierenHealthcare & Life Scienceshttps://arcorisbio.com/

Last Round

Seed

Nov 6, 2025

Total Funding Raised

$7.79M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

arcoris bio is a life science research tools and in vitro diagnostics company that develops a nanotechnology platform for biomarker detection and signal amplification to enable simultaneous detection of multiple biomarkers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryspatial multiomicsbiotech R&Ddrug developmentbiomarker detectionmultiplex immunofluorescencelife science toolsspatial biologybiopharmatherapeutic moleculeslab reagentspreclinical developmentwet-lab reagentsdiagnostic kits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

arcoris bio Comparables

Compare arcoris bio with similar companies based on industry and business-model similarity.

arcoris bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Navignostics AG
61%
Spatomics
44%
Amplifold
44%

arcoris bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 6, 2025

Key People

Founding team and executive leadership

Matyas Vegh

CEO

Executive Team

arcoris bio Investors

Notable investors and investment history

arcoris bio investors
InvestorRounds
Ventura AceSeed
Zurcher KantonalbankSeed
ZEISS VenturesSeed
VenturaSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 1994% MoM, reaching 4.8K.

  • Nov 6, 2025

    $8M round led by ZEISS Ventures and Ventura

Recent news

Latest coverage and updates

  • partners_withJul 22, 2026

    arcoris bio AG partnered with Europabiosite on Jul 21st '26.

  • launchesJul 22, 2026

    arcoris bio AG launched immunoMUSE kits on Jul 21st '26.

arcoris bio Filings

Explore SEC and related filing metadata, where available.

arcoris bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about arcoris bio's valuation, stock price, and market status.

Is arcoris bio a public or private company?

arcoris bio is a private company.

What is the current stock price of arcoris bio?

arcoris bio is a private company with no public stock price. No recent secondary market data is available.

How much is arcoris bio worth (valuation)?

Valuation information for arcoris bio is not publicly available.

Can I buy arcoris bio stock?

arcoris bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was arcoris bio's last funding round?

arcoris bio's most recent funding round was Seed on November 6, 2025.

Who are the main investors in arcoris bio?

Key investors in arcoris bio include ZEISS Ventures, Ventura.

Will arcoris bio IPO soon?

No public IPO plans have been announced for arcoris bio.

How can I track arcoris bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor arcoris bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSchlieren
Employee Range9
Year Founded2022
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?